April 21, 2020

Schwendinger M et al. J Infect Dis 2020;jiaa121.

A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus

Schwendinger M et al. J Infect Dis 2020

Download publication